A fascinating struggle between a long suffering shareholder who took a chance to get out, and the new blood who wants in.Bit more to play out yet, i think. This is just the end of round 4
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025